BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1379715)

  • 1. Lymphoid cells transformed by Abelson virus require the v-abl protein-tyrosine kinase only during early G1.
    Chen YY; Rosenberg N
    Proc Natl Acad Sci U S A; 1992 Aug; 89(15):6683-7. PubMed ID: 1379715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement.
    Chen YY; Wang LC; Huang MS; Rosenberg N
    Genes Dev; 1994 Mar; 8(6):688-97. PubMed ID: 7926759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ras complements the carboxyl terminus of v-Abl protein in lymphoid transformation.
    Parmar K; Rosenberg N
    J Virol; 1996 Feb; 70(2):1009-15. PubMed ID: 8551558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Active Akt and functional p53 modulate apoptosis in Abelson virus-transformed pre-B cells.
    Gong L; Unnikrishnan I; Raghavan A; Parmar K; Rosenberg N
    J Virol; 2004 Feb; 78(4):1636-44. PubMed ID: 14747529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncogenic v-Abl tyrosine kinase can inhibit or stimulate growth, depending on the cell context.
    Renshaw MW; Kipreos ET; Albrecht MR; Wang JY
    EMBO J; 1992 Nov; 11(11):3941-51. PubMed ID: 1396587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The extreme carboxyl terminus of v-Abl is required for lymphoid cell transformation by Abelson virus.
    Warren D; Griffin DS; Mainville C; Rosenberg N
    J Virol; 2003 Apr; 77(8):4617-25. PubMed ID: 12663768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo association of v-Abl with Shc mediated by a non-phosphotyrosine-dependent SH2 interaction.
    Raffel GD; Parmar K; Rosenberg N
    J Biol Chem; 1996 Mar; 271(9):4640-5. PubMed ID: 8617726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain.
    Mainville CA; Parmar K; Unnikrishnan I; Gong L; Raffel GD; Rosenberg N
    J Virol; 2001 Feb; 75(4):1816-23. PubMed ID: 11160680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-7 reconstitutes multiple aspects of v-Abl-mediated signaling.
    Banerjee A; Rothman P
    J Immunol; 1998 Nov; 161(9):4611-7. PubMed ID: 9794389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the Abelson tyrosine kinase activity is associated with suppression of apoptosis in hemopoietic cells.
    Evans CA; Owen-Lynch PJ; Whetton AD; Dive C
    Cancer Res; 1993 Apr; 53(8):1735-8. PubMed ID: 8467488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity.
    Engelman A; Rosenberg N
    J Virol; 1990 Sep; 64(9):4242-51. PubMed ID: 1696637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein phosphorylation at tyrosine residues in v-abl transformed mouse lymphocytes and fibroblasts.
    Saggioro D; Ferracini R; Di Renzo MF; Naldini L; Chieco-Bianchi L; Comoglio PM
    Int J Cancer; 1986 Apr; 37(4):623-8. PubMed ID: 2420727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth, differentiation, and malignant transformation of pre-B cells mediated by inducible activation of v-Abl oncogene.
    Jacobsen EA; Ananieva O; Brown ML; Chang Y
    J Immunol; 2006 Jun; 176(11):6831-8. PubMed ID: 16709843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A small molecule Abl kinase inhibitor induces differentiation of Abelson virus-transformed pre-B cell lines.
    Muljo SA; Schlissel MS
    Nat Immunol; 2003 Jan; 4(1):31-7. PubMed ID: 12469118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro transformation of murine pro-B and pre-B cells by v-mpl, a truncated form of a cytokine receptor.
    Fichelson S; Vigon I; Dusanter I; Charon M; Velu T; Baillou C; Gisselbrecht S; Lemoine FM
    J Immunol; 1995 Feb; 154(4):1577-86. PubMed ID: 7836743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Absence of p53 complements defects in Abelson murine leukemia virus signaling.
    Unnikrishnan I; Rosenberg N
    J Virol; 2003 Jun; 77(11):6208-15. PubMed ID: 12743277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonrandom cytogenetic changes accompany malignant progression in clonal lines abelson virus-infected lymphocytes.
    Clark SS; Liang Y; Reedstrom CK; Wu SQ
    Blood; 1994 Dec; 84(12):4301-9. PubMed ID: 7994046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cells arrested in G1 by the v-Abl tyrosine kinase do not express cyclin A despite the hyperphosphorylation of RB.
    Chen Y; Knudsen ES; Wang JY
    J Biol Chem; 1996 Aug; 271(33):19637-40. PubMed ID: 8702661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abelson virus transformation prevents TRAIL expression by inhibiting FoxO3a and NF-kappaB.
    Wilson MK; McWhirter SM; Amin RH; Huang D; Schlissel MS
    Mol Cells; 2010 Apr; 29(4):333-41. PubMed ID: 20213318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-B-cells transformed by ts Abelson virus rearrange kappa and lambda [correction of gamma] genes in early G1.
    Wang LC; Chen YY; Rosenberg N
    Curr Top Microbiol Immunol; 1995; 194():355-61. PubMed ID: 7895509
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.